GoldenGolden
Advanced Search
George Church

George Church

George Church is an American genetic scientist, Harvard University professor, and entrepreneur.

Overview

George Church is Professor of Genetics at Harvard Medical School, head of Synthetic Biology at Harvard's Weiss Institute, and Director of PersonalGenomes.org, which provides open-access information on human Genomic, Environmental & Trait data (GET). He received his PhD from Harvard in 1984.

He has contributed to many DNA sequencing methods and companies, including CGI-BGI, Life, Illumina, and Nanopore. He is director of an IARPA BRAIN Project and NIH Center for Excellence in Genomic Science. His honors include election to NAS & NAE & Franklin Bower Laureate for Achievement in Science. He has coauthored 453 papers, 105 patent publications, and one book, Regenesis..

In addition to his writing, Church was involved in the genesis of the Human Genome Project in 1984, Personal Genome Project in 2005 and has helped found over 30 startups. Church's PhD developed methods for direct genome sequencing, multiplexing and barcoding which directly led to the first genome sequence in 1994.

Career

Church has been involved in a large number of companies and institutions in his career, acting in a range of roles such as scientist, professor, founder and advisor. In addition to the companies he has co-founded, he currently works in an advisor role at multiple biochemistry and genealogy companies including Flagship Ventures, 23andMe, Good Start Genetics, Genia and Genome Compiler Corp.

Timeline

January 2009
Church becomes a founding member of the Wyss Institute for Biologically Inspired Engineering.
December 13, 2005
Church initiates the Personal Genome Project, an open-access human genome of trait data sets.
1984
Church publishes the first direct genomic sequencing method as part of his Ph.D in Biochemistry at Harvard University.
August 28, 1954
George Church was born.

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Famed geneticist George Church predicts the future of mankind

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Emma Betuel
September 13, 2021
TechCrunch
There are a growing number of companies interested in CRISPR's potential to upend medicine. It's probably safe to say there's only one company interested in using the gene-editing system to create a living, breathing woolly mammoth. Or, at least, something pretty close to it. That's the primary mission of a new company called Colossal. Co-founded [...]
Antonio Regalado
August 24, 2021
MIT Technology Review
Jason Kelly has promised a manufacturing revolution with DNA. Just don't ask him to make any products.
BioSpace
April 21, 2021
BioSpace
Seed Health, a microbial sciences company developing next-generation probiotic applications and live biotherapeutics, announced the close of a $40 million Series A financing led by impact investor, The Craftory, alongside TechBio investor ARTIS Ventures and life science investor GISEV, with participation from existing investors, Founders Fund and 8VC.
Andrea Park
April 20, 2021
FierceBiotech
Nowadays, you can buy pretty much any piece of digital memorabilia as a non-fungible token: a $69 million work of art, an X-ray of William Shatner's teeth and, soon, George Church's entire genome.
Amirah Al Idrus
April 19, 2021
FierceBiotech
Rejuvenate Bio raised more than $10 million in its series A round to propel its gene therapy toward the market for the treatment of heart disease in dogs and toward the clinic for the treatment of aging-related conditions in humans, including heart failure, kidney failure, Type 2 diabetes and obesity.
Laura Spinney
March 11, 2021
the Guardian
Designer babies and ethical quicksand ... The biographer of Steve Jobs tells the story of Jennifer Doudna and the development of gene-editing
Laura Spinney
March 11, 2021
the Guardian
Designer babies and ethical quicksand ... The biographer of Steve Jobs tells the story of Jennifer Doudna and the development of gene-editing
Angus Liu
February 10, 2021
FierceBiotech
The adeno-associated viruses often used as vectors to deliver gene therapy can trigger unwanted and sometimes dangerous immune responses. Now, a Harvard University team led by renowned geneticist George Church, Ph.D., has developed a way to "cloak" AAVs from immune surveillance. They've spun off Ally Therapeutics to develop it.
Heather Murphy
September 1, 2020
www.nytimes.com
Impatient for a coronavirus vaccine, dozens of scientists around the world are giving themselves -- and sometimes, friends and family -- their own unproven versions.
FinSMEs
May 11, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.